Bloodless Autologous Hematopoeitic Stem Cell Transplant: An Alternative for Jehovah's Witnesses and Others Who Prefer to Go Bloodless

被引：0
|
作者：
Llewellyn, Engaleisha L. I. [1 ]
Brown, Cheryl [2 ]
Shestovska, Yuliya [3 ]
Simmons-Massey, Kellie [4 ]
Fung, Henry C. [5 ]
Triplett, Allyson [1 ]
机构：
[1] Temple Univ Hosp & Med Sch, BMT, Philadelphia, PA 19140 USA
[2] Fox Chase Temple Univ Hosp, Bone Marrow Transplant Program, Philadelphia, PA USA
[3] Fox Chase Temple Univ Hosp, Philadelphia, PA USA
[4] Temple Univ Hosp & Med Sch, Blood Management Bloodless Med & Surg, Philadelhpia, PA USA
[5] Temple Univ Hosp & Med Sch, Fox Chase Canc Ctr, Dept Hematol & Oncol, Philadelphia, PA 19140 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
644
引用
收藏
页数：1
相关论文
共 25 条
  • [21] Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses
    Ford, Patricia A.
    Grant, Shakira J.
    Mick, Rosemarie
    Keck, Gina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15) : 1674 - +
  • [22] Autologous Stem Cell Transplantation without Hematopoietic Support for the Treatment of Hematological Malignancies in 125 Jehovah's Witnesses
    Grant, Shakira Jeanene
    Ford, Patricia
    Mick, Rosemarie
    Keck, Gina
    BLOOD, 2014, 124 (21)
  • [23] The effect of the dexamethasone, cytarabine, and cisplatin (DHAP) regimen on stem cell mobilization and transplant outcomes of patients with non-Hodgkin's lymphoma who are candidates for up-front autologous stem cell transplantation
    Jeon, So Yeon
    Yhim, Ho-Young
    Kim, Hee Sun
    Kim, Jeong-A
    Yang, Deok-Hwan
    Kwak, Jae-Yong
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2018, 33 (06): : 1169 - 1181
  • [24] Long Term Outcomes for Patient with Diffuse Large B-Cell (DLBCL) or Hodgkin's Lymphoma (HL) following Autologous Stem Cell Transplant (ASCT) Who Are Disease Free at Five Years Post Transplant
    Vose, Julie M.
    Loberiza, Fausto
    Bierman, Philip
    Bociek, Robert
    Armitage, James
    BLOOD, 2008, 112 (11) : 747 - 747
  • [25] A Phase II Study of Sepantronium Bromide (YM155) Plus Rituximab in Previously Treated Subjects with Aggressive CD20-Positive B Cell Non-Hodgkin's Lymphoma Who Are Ineligible for or Have Previously Received an Autologous Stem Cell Transplant - Stage I Results
    Papadopoulos, Kyriakos P.
    Smith, Scott E.
    Steinberg, Joyce
    Papa, Renelle
    Lopez-Jimenez, Javier
    Keating, Anne
    Thyss, Antoine
    BLOOD, 2012, 120 (21)
123